Mirikizumab-mrkz Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Mirikizumab-mrkz Injection (injection) from Eli Lilly and Co. with status To Be Discontinued. The shortage was first posted on 12/22/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Eli Lilly and Co.
- Package NDC
- 0002-8011-27
- Dosage Form
- Injection
- Presentation
- Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)
- Initial Posting
- 12/22/2025
- Revised Date